Happy New Year from Alberta’s Tomorrow Project (ATP)! We would like to thank participants for their years of participation and contributions to ATP. Their dedication over the last 20+ years has enabled the establishment of ATP as one of the largest and most valuable research platforms for supporting the future health of our province and to contribute to cancer and chronic disease research in Canada and around the world.
About Bud SkiffingtonThis author has not yet filled in any details.
So far Bud Skiffington has created 9 blog entries.
Sally`s fascination with research and a personal connection to the study has kept her contributing to Alberta`s largest research study for a decade. Born and raised in Saskatoon, Saskatchewan, Sally Mack has lived in Calgary for more than 30 years, and a participant of ATP since 2012. A medical representative by trade, she recalls the [...]
Want to know more about what happens to a sample after ATP collects it? Fred, an extroverted sample, shares his account firsthand. Hello. My name is Fred, your roving cryovial here reporting from Alberta Tomorrow’s Project (ATP) biobank to tell you what happens to us frozen samples when we are delivered to our home [...]
It is more than just a job, we really care and viscerally feel the value of ATP and how precious a project it isBud Skiffington 2021-12-22T08:58:37-07:00
“It is more than just a job, we really care and viscerally feel the value of ATP and how precious a project it is” Former Communications Advisor with ATP shares her journey of helping ATP’s platform grow into what it is today. Sharon Basaraba has worked as a storyteller in healthcare and medical news [...]
Alberta’s Tomorrow Project is celebrating 20 years since it first launched in 2001, and as a part of that, we are pleased to share initial findings from our COVID-19 Antibody (CAT) study and COVID-19 survey. The findings below reflect data collected and analyzed from when the study first began to the four-month follow-up appointment. We are seeing more than 96 per cent retention rate in this study, and we are thankful for our dedicated participants for helping us better understand the COVID-19 virus and how it influences the health
You have that sense you’re setting up a legacy, that you’re a part of a movement and that your participation will hold value for the future.Bud Skiffington 2021-12-14T10:10:01-07:00
Sandyne McCutcheon has been a participant with Alberta’s Tomorrow Project (ATP) for 15 years. She became aware of the study through a recruitment drive in St. Albert, Alberta. Sandyne’s initial interest in the study was piqued because of the fact it was following people over time to gain evidence, and she knew it was the right thing to do for that reason. “You knew this was going to be for the greater good, to be a part of something that’s larger than yourself,” reflects Sandyne. “We won’t likely know the direct impact or results of how we’ve
Alberta’s Tomorrow Project (ATP) first began to recruit Albertans in 2001 to help contribute to valuable cancer and chronic disease research. In the early days, the ATP team knew that recruiting 50,000 individuals was an ambitious goal, but early adopters like Ron Guidinger showed there were many generous Albertans inspired by the project’s vision. Ron, a former fighter pilot, signed up as an early participant of ATP as he saw it as an interesting and meaningful way to contribute to medical research. Ron recalls he didn’t know quite how many
Alberta’s Tomorrow Project (ATP) launched in 2001, making history as the province’s largest health research platform. Dr. Heather Bryant, former Vice-President of the Alberta Cancer Board and current Expert Advisor, Cancer Control with the Canadian Partnership Against Cancer, created this platform, with the goal of tracking thousands of adults over 50 years to better understand cancer and chronic disease, and how our genetics, lifestyle and behaviours could influence our health outcomes.
Alberta’s Tomorrow Project was invited to be a guest on Episode 51 of The Genetics Podcast hosted by Dr. Patrick Short, CEO of Sano Genetics. The podcast “explores all things genetics”, particularly highlighting aspects of genetics science and research. Previous guests have included leaders from other longitudinal cohort studies like ATP, such as Sir Rory Collins from the UK Biobank, and research platforms, such as Caroline Cake, CEO of Health Data Research UK.